{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:18:11Z","timestamp":1747167491052,"version":"3.40.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.mehy.2015.03.025","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T16:25:43Z","timestamp":1428251143000},"page":"76-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Is riluzole a potential therapy for Rett syndrome?"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9987-022X","authenticated-orcid":false,"given":"Shih-Jen","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2015.03.025_b0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12017-014-8295-9","article-title":"Rett syndrome and MeCP2","volume":"16","author":"Liyanage","year":"2014","journal-title":"NeuroMol Med"},{"key":"10.1016\/j.mehy.2015.03.025_b0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.mehy.2015.03.025_b0015","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(92)90610-O","article-title":"Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA","volume":"69","author":"Lewis","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2015.03.025_b0020","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0092-8674(00)81887-5","article-title":"MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin","volume":"88","author":"Nan","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2015.03.025_b0025","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.pedneo.2011.08.002","article-title":"Rett syndrome: from bed to bench","volume":"52","author":"Weng","year":"2011","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.mehy.2015.03.025_b0030","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.pediatrneurol.2011.12.003","article-title":"Use of buspirone and fluoxetine for breathing problems in Rett syndrome","volume":"46","author":"Gokben","year":"2012","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.mehy.2015.03.025_b0035","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0028-3908(85)90011-5","article-title":"2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission. I. Anticonvulsant properties","volume":"24","author":"Mizoule","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mehy.2015.03.025_b0040","first-page":"191","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"4","author":"Miller","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mehy.2015.03.025_b0045","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/cap.2010.0009","article-title":"Review of the use of the glutamate antagonist riluzole in psychiatric disorders and a description of recent use in childhood obsessive\u2013compulsive disorder","volume":"20","author":"Grant","year":"2010","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.mehy.2015.03.025_b0050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1517\/14728222.8.5.391","article-title":"Brain-derived neurotrophic factor as a drug target for CNS disorders","volume":"8","author":"Pezet","year":"2004","journal-title":"Exp Opin Therapeutic Targets"},{"key":"10.1016\/j.mehy.2015.03.025_b0055","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1046\/j.1471-4159.1999.0731409.x","article-title":"Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y","volume":"73","author":"Encinas","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2015.03.025_b0060","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.1086446","article-title":"Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2","volume":"302","author":"Chen","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.mehy.2015.03.025_b0065","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","article-title":"The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression","volume":"49","author":"Chang","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.mehy.2015.03.025_b0070","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4161\/epi.2.4.5212","article-title":"MeCP2 deficiency in the brain decreases BDNF levels by REST\/CoREST-mediated repression and increases TRKB production","volume":"2","author":"Abuhatzira","year":"2007","journal-title":"Epigenetics"},{"key":"10.1016\/j.mehy.2015.03.025_b0075","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/hmg\/ddm007","article-title":"FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice","volume":"16","author":"Deng","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.mehy.2015.03.025_b0080","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1212\/01.wnl.0000304086.75913.b2","article-title":"The p.Val66Met polymorphism in the BDNF gene protects against early seizures in Rett syndrome","volume":"70","author":"Nectoux","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2015.03.025_b0085","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1212\/01.wnl.0000345664.72220.6a","article-title":"The common BDNF polymorphism may be a modifier of disease severity in Rett syndrome","volume":"72","author":"Zeev","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2015.03.025_b0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/978-3-642-45106-5_18","article-title":"Brain-derived neurotrophic factor and Rett syndrome","volume":"220","author":"Katz","year":"2014","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.mehy.2015.03.025_b0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.nbd.2008.12.011","article-title":"BDNF overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations","volume":"34","author":"Larimore","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.mehy.2015.03.025_b0100","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.mehy.2006.02.029","article-title":"Lithium and antidepressants: potential agents for the treatment of Rett syndrome","volume":"67","author":"Tsai","year":"2006","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2015.03.025_b0105","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.resp.2007.08.009","article-title":"Oral treatment with desipramine improves breathing and life span in Rett syndrome mouse model","volume":"160","author":"Zanella","year":"2008","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.mehy.2015.03.025_b0110","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/j.1460-9568.2007.05466.x","article-title":"Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome","volume":"25","author":"Roux","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.mehy.2015.03.025_b0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3940(01)02098-5","article-title":"Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes","volume":"310","author":"Mizuta","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2015.03.025_b0120","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00259-009-1103-3","article-title":"Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins","volume":"36","author":"Squitieri","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.mehy.2015.03.025_b0125","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1096\/fj.02-0143fje","article-title":"Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus","volume":"16","author":"Katoh-Semba","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.mehy.2015.03.025_b0130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.expneurol.2005.11.010","article-title":"Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease","volume":"198","author":"Fumagalli","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/j.mehy.2015.03.025_b0135","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1111\/j.1460-9568.2006.05218.x","article-title":"Riluzole promotes cell survival and neurite outgrowth in rat sensory neurones in vitro","volume":"24","author":"Shortland","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.mehy.2015.03.025_b0140","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.neuroscience.2007.09.076","article-title":"Enhanced cell death in MeCP2 null cerebellar granule neurons exposed to excitotoxicity and hypoxia","volume":"150","author":"Russell","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2015.03.025_b0145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neuroscience.2005.08.054","article-title":"The metabotropic glutamate receptor subtype 5 antagonist MPEP and the Na+ channel blocker riluzole show different neuroprotective profiles in reversing behavioral deficits induced by excitotoxic prefrontal cortex lesions","volume":"137","author":"Risterucci","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2015.03.025_b0150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuroscience.2004.01.019","article-title":"Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes)","volume":"125","author":"Wang","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2015.03.025_b0155","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0006-8993(00)02430-6","article-title":"Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes","volume":"871","author":"Azbill","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2015.03.025_b0160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/B:CEMN.0000012717.37839.07","article-title":"Riluzole enhances glutamate uptake in rat astrocyte cultures","volume":"24","author":"Frizzo","year":"2004","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.mehy.2015.03.025_b0165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pediatrneurol.2012.11.001","article-title":"Rett syndrome and epilepsy: an update for child neurologists","volume":"48","author":"Dolce","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.mehy.2015.03.025_b0170","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1212\/WNL.47.6_Suppl_4.233S","article-title":"The pharmacology and mechanism of action of riluzole","volume":"47","author":"Doble","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2015.03.025_b0175","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuroscience.2007.04.018","article-title":"Anti-glutamatergic effect of riluzole: comparison with valproic acid","volume":"147","author":"Kim","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2015.03.025_b0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1258\/ebm.2010.010261","article-title":"Experimental models of Rett syndrome based on Mecp2 dysfunction","volume":"236","author":"Calfa","year":"2011","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.mehy.2015.03.025_b0185","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.neuropharm.2013.03.024","article-title":"BDNF deregulation in Rett syndrome","volume":"76 Pt C","author":"Li","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mehy.2015.03.025_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2015.01.001","article-title":"MECP2e1 isoform mutation affects the form and function of neurons derived from Rett syndrome patient iPS cells","author":"Djuric","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.mehy.2015.03.025_b0195","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00213-011-2403-4","article-title":"Antidepressant-like properties of oral riluzole and utility of incentive disengagement models of depression in mice","volume":"219","author":"Gourley","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.mehy.2015.03.025_b0200","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.brainres.2004.06.002","article-title":"Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease","volume":"1019","author":"Ishiyama","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2015.03.025_b0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0166-2236(00)01682-9","article-title":"BDNF and epilepsy: too much of a good thing?","volume":"24","author":"Binder","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.mehy.2015.03.025_b0210","doi-asserted-by":"crossref","first-page":"13208","DOI":"10.1073\/pnas.0605180103","article-title":"Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects","volume":"103","author":"Govindarajan","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2015.03.025_b0215","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1182\/blood-2004-08-3096","article-title":"A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival","volume":"105","author":"Pearse","year":"2005","journal-title":"Blood"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987715001401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987715001401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T19:53:34Z","timestamp":1566503614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987715001401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0306987715001401"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2015.03.025","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is riluzole a potential therapy for Rett syndrome?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2015.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}